PFZ Pfizer

TIDMPFZ

RNS Number : 6886G

JPMorgan Securities Plc

23 November 2015

Ap24

FORM 38.5(a)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

   1.       KEY INFORMATION 
 
Name of exempt principal  J.P. Morgan Securities 
 trader                    plc 
========================  ====================== 
Company dealt in          Pfizer Inc 
========================  ====================== 
Class of relevant         Common Stock 
 security to which 
 the dealings being 
 disclosed relate 
 (Note 1) 
========================  ====================== 
Date of dealing           20 November 2015 
========================  ====================== 
 
   2.        DEALINGS (Note 2) 
   (a)      Purchases and sales 
 
 Total number         Highest price paid     Lowest price 
  of relevant          (EUR)                  paid (EUR) 
  secuities 
  acquired 
                       (Note 3)               (Note 3) 
=============  =========================  =============== 
 
 
 
 Total number           Highest price received     Lowest price 
  of securities          (USD) (Note 3)             received (EUR) 
  disposed 
                                                    (Note 3) 
===============  =============================  ================== 
      563                   30.4850                  30.4750 
===============  =============================  ================== 
 
   (b)      Derivatives transactions (other than options transactions) 
 
 Product      Nature of       Number of relevant    Price per 
  name,        transaction     securities           unit (EUR) 
  e.g. CFD     (Note 4)        (Note 5)              (Note 3) 
===========  ==============  ===================  ============ 
  Equity 
    Swap          Long               563            30.4751 
===========  ==============  ===================  ============ 
 
   (c)      Options transactions in respect of existing relevant securities 
   (i)       Writing, selling, purchasing or varying 
 
 Product   Writing,      Number           Exercise   Type,       Expiry   Option 
  name,     selling,      of securities    price      e.g.        date     money 
  e.g.      purchasing,   to which                    American,            paid/received 
  call      varying       the option                  European             per unit 
  option    etc.          relates                     etc.                 (Note 
                          (Note                                            3) 
                          5) 
========  =============  ==============  =========  ===========  ======  =============== 
 
 
   (ii)      Exercising 
 
Product name,         Number of securities      Exercise price 
 e.g. call                                       per unit (Note 
 option                                          3) 
=============  ===========================  =================== 
 
 

Ap25

   3.      OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities

under any option referred to on this form or relating to the voting rights or future acquisition

or disposal of any relevant securities to which any derivative referred to on this form is referenced.

If none, this should be stated.

 
Date of disclosure        23 November 2015 
========================  =================== 
Contact name              Tung Le 
========================  =================== 
Telephone number          020 7742 7272 
========================  =================== 
Name of offeree/offeror   Allergan Plc 
 with which connected 
========================  =================== 
Nature of connection      Adviser to Allergan 
 (Note 6)                  Plc 
========================  =================== 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

FERUORWRVKAAUAA

(END) Dow Jones Newswires

November 23, 2015 13:11 ET (18:11 GMT)

Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025

Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025